• Targeting GOT1 for Metabolic Disruption in Pancreatic Cancer

  2026-05-02

  This study identifies ziprasidone as a novel non-competitive inhibitor of GOT1, disrupting glutamine metabolism and redox balance in pancreatic ductal adenocarcinoma (PDAC) cells. The findings provide mechanistic insight into metabolic vulnerabilities in PDAC and highlight GOT1 inhibition as a promising therapeutic strategy.

• PTX3-TLR4/NF-κB-FGF21 Axis in Glucocorticoid-Induced ONFH

  2026-05-01

  This study uncovers a protective mechanism in glucocorticoid-induced osteonecrosis of the femoral head (ONFH), identifying PTX3 as a modulator of the TLR4/NF-κB/FGF21 signaling axis. The findings reveal potential therapeutic targets and inform future osteoclastogenesis research and intervention strategies.

• JNJ-26481585 (Quisinostat): Applied Workflows for Tumor Assa

  2026-04-30

  JNJ-26481585 (Quisinostat) empowers cancer researchers to dissect epigenetic modulation, induce apoptosis, and overcome drug resistance in advanced tumor models. This guide details robust experimental workflows, actionable protocol parameters, and troubleshooting strategies, all underpinned by the latest TRIM21–ERK1/2 research and APExBIO’s trusted supply chain.

• Advancing Mammalian Cell Viability: Insights with Calcein AM

  2026-04-30

  Explore how the Live-Dead Cell Staining Kit I (Calcein AM/PI) delivers rigorous, real-time assessment of mammalian cell viability and cytotoxicity. This article uniquely bridges advanced assay science with translational research, offering deep protocol and mechanistic guidance.

• EdU Imaging Kits (HF594): Technical Guide for Proliferation

  2026-04-29

  EdU Imaging Kits (HF594) enable direct, sensitive detection of DNA synthesis as a measure of cell proliferation, streamlining workflows that previously relied on more disruptive methods. Recommended for applications in cell proliferation assays by fluorescence microscopy or flow cytometry, these kits should not be used where antibody-based detection or native DNA structure is required. Not suitable for live-cell tracking or when copper-free environments are essential.

• Protein A/G Magnetic Beads: Protocol and QC for Antibody Cap

  2026-04-29

  Protein A/G Magnetic Beads provide a reproducible tool for capturing and purifying IgG antibodies from complex biological samples, including serum and cell culture supernatants. They are best used in immunoprecipitation, co-immunoprecipitation, and chromatin IP workflows where specificity and low background are critical. Not suitable for diagnostic or medical applications, and should not be substituted for beads designed for non-IgG isotypes.

• Laminin (925-933): Protocol Guidance for Cell Adhesion Assay

  2026-04-28

  Laminin (925-933) is a defined laminin B1 chain peptide designed for reproducible cell adhesion, migration, and chemotaxis assays. It is best suited for applications requiring quantitative modulation of cell–matrix interactions, but should not be used for diagnostic or therapeutic purposes. Researchers should adhere closely to product-specific concentrations and solubility guidelines to ensure assay reliability.

• Cisplatin (CDDP) in Cancer Research: Protocols, Resistance,

  2026-04-28

  Cisplatin (CDDP) is a gold-standard DNA crosslinking agent powering apoptosis assays and tumor growth inhibition studies in cancer research. This article delivers hands-on workflow guidance, resistance modeling strategies, and actionable troubleshooting tips for maximizing experimental reproducibility—anchored by the latest mechanistic discoveries and APExBIO's rigorous product specifications.

• Saracatinib (AZD0530): Src/Abl Inhibition and the Reelin-SFK

  2026-04-27

  Explore how Saracatinib (AZD0530) advances cancer research by inhibiting Src/Abl kinases and modulating the Reelin-SFK signaling axis. This article uniquely connects molecular mechanisms to practical assay design, providing insights unavailable in standard protocols.

• ERK-Driven Apoptosis in IFNγ-Treated Melanoma: Mechanistic I

  2026-04-27

  Champhekar et al. (2023) identify ERK activation as a central mediator of interferon-gamma (IFNγ)-induced apoptosis in melanoma cells, clarifying a key signaling route for tumor growth inhibition. Their integrated chemical genomics and functional genomics approach highlights new mechanistic targets for cancer immunotherapy, with practical relevance for pathway-focused research.

• Resibufogenin Inhibits NLRP3 Inflammasome to Reduce Atherosc

  2026-04-26

  This study demonstrates that resibufogenin (RBG) suppresses atherosclerosis progression in ApoE-/- mice by directly inhibiting NLRP3 inflammasome assembly. The findings reveal both molecular and cellular mechanisms by which RBG modulates inflammation and macrophage polarization, offering a promising strategy for targeted cardiovascular therapy.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-04-25

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, capturing the cellular heterogeneity and microenvironment of primary tumors more faithfully than organoids alone. The model enables nuanced analysis of drug responses and resistance mechanisms, providing a platform for personalized therapeutic screening and translational cancer research.

• Fludarabine: Precision DNA Synthesis Inhibitor for Oncology

  2026-04-24

  Fludarabine is a purine analog DNA synthesis inhibitor with verified efficacy in apoptosis induction and cell cycle arrest. It is essential in leukemia and multiple myeloma research models and supports workflows requiring robust, reproducible DNA replication inhibition.

• MSH2 Loss Drives Cisplatin Resistance in Bladder Cancer Cell

  2026-04-24

  A whole-genome CRISPR screen in muscle-invasive bladder cancer cells identified MSH2 as a critical determinant of cisplatin sensitivity. These findings suggest that MSH2 protein levels may serve as a predictive biomarker for platinum-based chemotherapy response, enabling better patient stratification.

• Spermine: Applied Protocols for Ion Channel and Cell Growth

  2026-04-23

  Harness the unique properties of Spermine—an endogenous polyamine—for precision modulation of inward rectifier potassium channels and advanced cell metabolism studies. This guide delivers workflow-centric protocols, troubleshooting tips, and actionable insights translating recent breakthroughs in nuclear membrane dynamics into practical research advantages.

16251 records 1/1084 page Next 12345 下5页 Last page